Long-Term Efficacy and Safety of Taletrectinib in Patients With <i>ROS1</i> + Non–Small Cell Lung Cancer: Results From the Phase II TRUST-I Study

Authors

Huijie Fan (ORCID: https://orcid.org/0009-0005-3970-7980)
Wenfeng Chen (ORCID: https://orcid.org/0000-0002-9507-1711)
Wei Li (ORCID: https://orcid.org/0000-0001-7960-0372)
Feiwu Ran
Caicun Zhou (ORCID: https://orcid.org/0000-0002-1072-9941)
Yongchang Zhang (ORCID: https://orcid.org/0000-0002-6829-7176)
Qitao Yu

Institutions

Central South University (CN)
Shanghai Cancer Institute (CN)
Hunan Cancer Hospital (CN)
Nuvotronics (United States) (US)
Shanghai Pulmonary Hospital (CN)
Shanghai East Hospital (CN)
Tumor Hospital of Guangxi Medical University (CN)
First Affiliated Hospital of Zhengzhou University (CN)

Publication Details

Journal: Journal of Clinical Oncology
Published: 2026-04-21
DOI: https://doi.org/10.1200/jco-26-00434
Primary Topic: Lung Cancer Treatments and Mutations
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Long-Term Efficacy and Safety of Taletrectinib in Patients With ROS1 + Non–Small Cell Lung Cancer: Results From the Phase II TRUST-I Study

Huijie Fan, Wenfeng Chen, Wei Li, Feiwu Ran et al.

Apr 21, 2026

Journal of Clinical Oncology

Lung Cancer Treatments and Mutations

article

Long-Term Efficacy and Safety of Taletrectinib in Patients With ROS1 + Non–Small Cell Lung Cancer: Results From the Phase II TRUST-I Study

Huijie Fan, Wenfeng Chen, Wei Li, Feiwu Ran, Caicun Zhou, Yongchang Zhang, Qitao Yu

April 21, 2026article en

Abstract

No abstract available for this paper.

Journal of Clinical Oncology

Central South University (CN), Shanghai Cancer Institute (CN), Hunan Cancer Hospital (CN), Nuvotronics (United States) (US), Shanghai Pulmonary Hospital (CN), Shanghai East Hospital (CN), Tumor Hospital of Guangxi Medical University (CN), First Affiliated Hospital of Zhengzhou University (CN)

Good health and well-being

Openalex Percentile: Top 12%

Lung Cancer Treatments and Mutations

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.